Skip to main content

Day: April 6, 2020

STRATA Skin Sciences, Inc. Announces Study Published in the Journal of Drugs in Dermatology

HORSHAM, Pa., April 06, 2020 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the peer-reviewed publication of a clinical study report entitled: “Treatment of Plaque Psoriasis with an Excimer Laser Utilizing an Optimal Therapeutic UVB Dose Protocol” in the April, 2020 issue of the Journal of Drugs in Dermatology.The article, authored by Quinn Thibodeaux, MD, Kristen Beck, MD, Benjamin N. Lockshin, MD, Neal Bhatia, MD, Ethan Levin, MD, John Koo, MD, and Tina Bhutani, MD, summarizes the results of a multi-center clinical study investigating the efficiency and efficacy of the Multi-Micro Dose®...

Continue reading

Titan Machinery Announces Entry into New Amended and Restated Credit Agreement

WEST FARGO, N.D., April 06, 2020 (GLOBE NEWSWIRE) — Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, announced today that it has entered into a new five-year Amended and Restated Credit Agreement, maturing April 2025, arranged by Bank of America, with a syndicate of lenders consisting of Bank of America, Wells Fargo Bank, Regions Bank, BBVA USA, AgCountry Farm Credit Services, and Sterling National Bank.The new Amended and Restated Credit Agreement provides for an aggregate $250 million financing commitment by the lenders, consisting of an aggregate floorplan financing commitment of $185 million and an aggregate working capital commitment of $65 million. The floorplan facility may be used to advance up to 85% of the value of eligible new inventory and up to 75%...

Continue reading

KAIVAL BRANDS ENTERS INTO NON-EXCLUSIVE SUB-DISTRIBUTION AGREEMENT WITH MINIMUM PURCHASE OBLIGATIONS

GRANT, Fla., April 06, 2020 (GLOBE NEWSWIRE) — Kaival Brands Innovations Group, Inc. (OTC PINK: KAVL) (“Kaival Brands,” the “Company,” “we,” or “our”), a company focused on growing and incubating innovative and profitable products into mature, dominant brands, today announced that it has entered into a Non-Exclusive Sub-Distribution Agreement (the “Agreement”) with Favs Business, LLC, a Georgia limited liability company (“Favs”), pursuant to which Favs will be appointed as a non-exclusive sub-distributor of electronic nicotine delivery systems and related components (the “Products”) solely to non-retail level customers, including without limitation, to wholesale customers and sub-distributors.  The Agreement was entered into in connection with that certain exclusive distribution agreement, dated March 9, 2020 (the “Distribution Agreement”),...

Continue reading

Builders FirstSource Provides Update Related to COVID-19

DALLAS, April 06, 2020 (GLOBE NEWSWIRE) — Builders FirstSource, Inc. (Nasdaq:  BLDR) remains focused on prioritizing the safety and well-being of our team members, customers and communities as we continue to supply our essential products and services amid the global COVID-19 pandemic.Operating with a Safety-First ApproachBuilders FirstSource locations remain open and operational except in the few states or counties where construction activities have been prohibited. As an essential supplier of diversified products and services to builders and contractors, we have strictly adhered to the recommendations and guidelines promoted by the Centers for Disease Control and Prevention (CDC) and local community health departments where we operate.In recent months, we have proactively implemented business continuity measures across our network...

Continue reading

Live Ventures Provides Business Update

LAS VEGAS, April 06, 2020 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE), a diversified holding company, today provided a business update in response to the COVID-19 pandemic.Vintage Stock has temporarily closed all of its retail stores and expects stores to remain closed until permitted to reopen by government authorities.  Vintage Stock continues to operate and serve its customers online at www.vintagestock.com.Marquis Industries, a national carpet manufacturer and hard surface flooring supplier, is continuing to operate on a scaled down basis to meet continuing demand and service its customers.  Sales, administration, warehouse, distribution and some manufacturing facilities remain open with temporarily reduced staffing.  Marquis has agreed to file for unemployment benefits for employees who are temporarily furloughed...

Continue reading

SHOCKWAVE COMPLETES ENROLLMENT IN PIVOTAL STUDY FOR CORONARY INTRAVASCULAR LITHOTRIPSY

SANTA CLARA, Calif., April 06, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company has completed enrollment in the pivotal U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study – DISRUPT CAD III – for the use of IVL in heavily calcified coronary arteries. The investigational Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, which has been granted Breakthrough Device Designation by the FDA, is an innovative therapy designed to fracture problematic calcium using sonic pressure waves in order to facilitate stent delivery, deployment and optimal expansion.The co-principal investigators of the study are Dean...

Continue reading

Aprea Therapeutics Launches New Corporate Website – www.aprea.com

BOSTON, April 06, 2020 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics to reactivate mutant tumor suppressor protein, p53, today announced that it has launched a new, redesigned website, www.aprea.com. With an updated design, the new aprea.com web-site offers easy-to-navigate functionality and a content-rich site experience created to provide fulsome information on Aprea’s scientific focus, strategy and progress as the leader in developing important anti-cancer therapies to reactivate the tumor suppressor protein, p53.About Aprea Therapeutics, Inc.Aprea Therapeutics, Inc. is a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing...

Continue reading

Silk Road Medical Provides COVID-19 Pandemic Update

SUNNYVALE, Calif., April 06, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today provided a corporate update in response to the COVID-19 pandemic.Silk Road Medical is committed to working closely with its partners as part of the coordinated public and private sector response to this unforeseen event. The Company is proactively taking the following steps:Protecting the health and wellbeing of employees and others: In line with recommendations from federal and local government and healthcare agencies, Silk Road Medical has transitioned employees, except for those deemed essential to key aspects of the business, to a remote work environment. The Company has also made cash and personal protective equipment donations to local and national organizations...

Continue reading

Heart Valves Market to Exhibit 11.7% CAGR by 2026; Rising Geriatric Population with Growing Number of Cardiovascular Disorders Will Attract High Revenue: Fortune Business Insights™

Pune, April 06, 2020 (GLOBE NEWSWIRE) — The global Heart Valves market size is expected to reach USD 15.98 billion by 2026, on account of the advent of customized Heart Valvess. A Heart Valves allows blood to flow in only one direction through the heart. Blood passes through a valve before leaving every chamber of the heart. These valves helps to abstain the backward flow of blood. A recently published report by Fortune Business Insights™ titled, “Heart Valves Market Size, Share & Industry Analysis, By Product Type (Replacement (Aortic, Mitral, and Others), and Repair), By Valve Type (Tissue Valve and Mechanical Valve), By Procedure (Surgical and Transcatheter), By End User (Hospitals, and Specialty Clinics & Others), and Regional Forecast, 2019-2026” discusses the market and its growth parameters in details. As per this...

Continue reading

Change of Dividend Record Date

Albion Development VCT PLCLEI CODE 213800FDDMBD9QLHLB38Change of Dividend Record Date                                                                                                                                     Further to the announcement of Albion Development VCT PLC’s Annual Report and Financial Statements for the year ended 31 December 2019 made on 27 March 2020, the Board announces that the dividend record date has been changed from 8 May 2020 to 11 May 2020.All other information relating to the dividend contained in the announcement remains unchanged.6 April 2020Albion Capital Group LLPCompany SecretaryTel: 020 7601 1850

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.